• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炭疽芽孢杆菌毒素保护性抗原和致死因子成分的免疫电泳分析、毒性及体外产生动力学

Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

作者信息

Ezzell J W, Ivins B E, Leppla S H

出版信息

Infect Immun. 1984 Sep;45(3):761-7. doi: 10.1128/iai.45.3.761-767.1984.

DOI:10.1128/iai.45.3.761-767.1984
PMID:6432700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC263363/
Abstract

The kinetics of Bacillus anthracis toxin production in culture and its lethal activity in rats, mice, and guinea pigs were investigated. Lethal toxin activity was produced in vitro throughout exponential growth at essentially identical rates in both encapsulated virulent and nonencapsulated avirulent strains. The two toxin proteins which produce lethality when in combination, lethal factor (LF) and protective antigen (PA), could be quantitated directly from culture fluids by rocket immunoelectrophoresis. Using purified preparations of these proteins, we determined that a combination of 8 micrograms of LF and 40 micrograms of PA was required for a maximal rate of killing (39 to 40 min) in Fischer 344 rats (250 to 300 g). Conversely, a minimum of 0.6 microgram of LF and 3 micrograms of PA was required for lethality. The 50% lethal dose for Hartley guinea pigs was 50 micrograms of LF and 250 micrograms of PA, and for Swiss mice it was 2.5 micrograms of LF and 12.5 micrograms of PA. Analyses classically reserved for enzyme kinetic studies were used to study the kinetics of lethal activity in the rat model after intravenous injection of LF-PA mixtures. The amounts of LF and PA which were required to give half the rate of killing (i.e., double the minimum time to death) were 1.2 and 5.8 micrograms, respectively. A theoretical minimum time to death was determined to be 38 min. A third anthrax toxin component, edema factor, was shown to inhibit lethal toxin activity. Edema factor could not be quantitated by rocket immunoelectrophoresis because the protein did not form distinct precipitin bands with available antisera.

摘要

研究了炭疽芽孢杆菌毒素在培养物中的产生动力学及其在大鼠、小鼠和豚鼠中的致死活性。在指数生长阶段,有荚膜的强毒株和无荚膜的无毒株在体外均以基本相同的速率产生致死毒素活性。当组合时产生致死性的两种毒素蛋白,致死因子(LF)和保护性抗原(PA),可通过火箭免疫电泳直接从培养液中定量。使用这些蛋白的纯化制剂,我们确定在Fischer 344大鼠(250至300克)中,最大杀伤速率(39至40分钟)需要8微克LF和40微克PA的组合。相反,致死性至少需要0.6微克LF和3微克PA。Hartley豚鼠的半数致死剂量为50微克LF和250微克PA,瑞士小鼠的半数致死剂量为2.5微克LF和12.5微克PA。采用经典的酶动力学研究分析方法,研究静脉注射LF-PA混合物后大鼠模型中致死活性的动力学。产生半数杀伤速率(即死亡最短时间加倍)所需的LF和PA量分别为1.2微克和5.8微克。理论上最短死亡时间确定为38分钟。炭疽毒素的第三种成分水肿因子被证明可抑制致死毒素活性。由于该蛋白与现有抗血清不能形成明显的沉淀带,因此不能通过火箭免疫电泳对水肿因子进行定量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/263363/5df4272a1615/iai00126-0236-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/263363/440f854a2363/iai00126-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/263363/5df4272a1615/iai00126-0236-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/263363/440f854a2363/iai00126-0235-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e0/263363/5df4272a1615/iai00126-0236-a.jpg

相似文献

1
Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.炭疽芽孢杆菌毒素保护性抗原和致死因子成分的免疫电泳分析、毒性及体外产生动力学
Infect Immun. 1984 Sep;45(3):761-7. doi: 10.1128/iai.45.3.761-767.1984.
2
Contribution of individual toxin components to virulence of Bacillus anthracis.炭疽芽孢杆菌单个毒素成分对毒力的贡献。
Infect Immun. 1991 Oct;59(10):3472-7. doi: 10.1128/iai.59.10.3472-3477.1991.
3
Role of toxin functional domains in anthrax pathogenesis.毒素功能结构域在炭疽病发病机制中的作用。
Infect Immun. 2000 Apr;68(4):1781-6. doi: 10.1128/IAI.68.4.1781-1786.2000.
4
A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.一种新型三重嵌合蛋白作为炭疽毒素的高免疫原性抗原:理论和实验分析。
Immunopharmacol Immunotoxicol. 2019 Feb;41(1):25-31. doi: 10.1080/08923973.2018.1510419. Epub 2019 Jan 9.
5
Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.针对炭疽芽孢杆菌保护性抗原的单克隆抗体在体内增强致死毒素活性。
FEMS Immunol Med Microbiol. 2011 Jun;62(1):11-22. doi: 10.1111/j.1574-695X.2011.00782.x. Epub 2011 Feb 2.
6
Protective immunity induced by Bacillus anthracis toxin-deficient strains.炭疽芽孢杆菌毒素缺陷菌株诱导的保护性免疫
Infect Immun. 1995 Apr;63(4):1369-72. doi: 10.1128/iai.63.4.1369-1372.1995.
7
Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.炭疽致死毒素(LeTx)被PA结构域特异性抗血清中和。
Toxicon. 2017 Dec 1;139:58-65. doi: 10.1016/j.toxicon.2017.09.008. Epub 2017 Sep 14.
8
[Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].[转基因小鼠中全人源炭疽致死因子中和抗体的筛选]
Sheng Wu Gong Cheng Xue Bao. 2016 Nov 25;32(11):1590-1599. doi: 10.13345/j.cjb.160049.
9
Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.炭疽芽孢杆菌新型嵌合PA-LF抗原的研制、免疫学特性及其作为小鼠模型中未来疫苗候选物的评估
Biologicals. 2019 Sep;61:38-43. doi: 10.1016/j.biologicals.2019.07.004. Epub 2019 Aug 13.
10
The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.抗炭疽芽孢杆菌抗体和炭疽毒素成分在抑制炭疽芽孢感染早期阶段中的作用。
Microbiology (Reading). 2001 Jun;147(Pt 6):1677-1685. doi: 10.1099/00221287-147-6-1677.

引用本文的文献

1
Role of serine/threonine protein phosphatase PrpN in the life cycle of Bacillus anthracis.丝氨酸/苏氨酸蛋白磷酸酶 PrpN 在炭疽芽孢杆菌生命周期中的作用。
PLoS Pathog. 2022 Aug 1;18(8):e1010729. doi: 10.1371/journal.ppat.1010729. eCollection 2022 Aug.
2
Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc Mice.气溶胶气管内接种重组保护性抗原(rPA)疫苗可预防 B10.D2-Hc 小鼠吸入性炭疽。
Front Immunol. 2022 Jan 26;13:819089. doi: 10.3389/fimmu.2022.819089. eCollection 2022.
3
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.

本文引用的文献

1
QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS.粗制炭疽毒素的定量测定
J Bacteriol. 1965 Jan;89(1):74-83. doi: 10.1128/jb.89.1.74-83.1965.
2
MANGANESE REQUIREMENT FOR SPORULATION AND OTHER SECONDARY BIOSYNTHETIC PROCESSES OF BACILLUS.芽孢杆菌芽孢形成及其他次生生物合成过程对锰的需求
Appl Microbiol. 1964 Sep;12(5):436-41. doi: 10.1128/am.12.5.436-441.1964.
3
The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity.炭疽毒素的三个因素:它们的免疫原性以及缺乏可证实的酶活性。
一种改良炭疽毒素对犬和人骨肉瘤细胞的抑制作用。
Toxins (Basel). 2020 Sep 24;12(10):614. doi: 10.3390/toxins12100614.
4
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.重组炭疽毒素对犬口腔黏膜黑色素瘤的抑制作用。
Toxins (Basel). 2020 Mar 2;12(3):157. doi: 10.3390/toxins12030157.
5
The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.毒素通过离散通道与细胞内信号传导相互作用的分子基础。
Toxins (Basel). 2017 Mar 16;9(3):107. doi: 10.3390/toxins9030107.
6
Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives.姜黄素及化学修饰的姜黄素衍生物对炭疽致死因子的抑制作用。
J Enzyme Inhib Med Chem. 2014 Oct;29(5):663-9. doi: 10.3109/14756366.2013.837901. Epub 2013 Oct 9.
7
Pathology and pathophysiology of inhalational anthrax in a guinea pig model.吸入性炭疽在豚鼠模型中的病理学和病理生理学。
Infect Immun. 2013 Apr;81(4):1152-63. doi: 10.1128/IAI.01289-12. Epub 2013 Jan 28.
8
Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.炭疽杆菌致死毒素降低人肺泡上皮屏障功能。
Infect Immun. 2012 Dec;80(12):4374-87. doi: 10.1128/IAI.01011-12. Epub 2012 Oct 1.
9
From structure to solutions: the role of basic research in developing anthrax countermeasures: Microbiology Graduate Program Seminar: Anthrax toxin.从结构到解决方案:基础研究在开发炭疽对策中的作用:微生物学研究生课程研讨会:炭疽毒素。
Yale J Biol Med. 2012 Jun;85(2):285-92. Epub 2012 Jun 25.
10
Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment.可溶性炭疽毒素受体诱饵-Ig 融合蛋白治疗相关迟发性毒性。
PLoS One. 2012;7(4):e34611. doi: 10.1371/journal.pone.0034611. Epub 2012 Apr 12.
J Gen Microbiol. 1963 May;31:329-37. doi: 10.1099/00221287-31-2-329.
4
Purification of factor I and recognition of a third factor of the anthrax toxin.炭疽毒素因子I的纯化及第三种炭疽毒素因子的鉴定
J Gen Microbiol. 1961 Sep;26:49-63. doi: 10.1099/00221287-26-1-49.
5
Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis.炭疽芽孢杆菌毒素分级分离时发现的第三种成分对大鼠的快速致死作用。
J Bacteriol. 1962 Jun;83(6):1274-80. doi: 10.1128/jb.83.6.1274-1280.1962.
6
Production of toxin in vitro by Bacillus anthracis and its spearation into two components.炭疽芽孢杆菌在体外产生毒素及其分离为两个组分。
J Bacteriol. 1960 Mar;79(3):450-5. doi: 10.1128/jb.79.3.450-455.1960.
7
Biochemical properties of virulent and avirulent strains of Bacillus anthracis.炭疽芽孢杆菌强毒株和无毒株的生化特性
Ann N Y Acad Sci. 1960 Nov 21;88:1024-33. doi: 10.1111/j.1749-6632.1960.tb20094.x.
8
Production in vitro of the toxin of Bacillus anthracis previously recognized in vivo.炭疽芽孢杆菌毒素的体外制备,该毒素此前已在体内得到确认。
J Gen Microbiol. 1958 Aug;19(1):91-103. doi: 10.1099/00221287-19-1-91.
9
An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production.一种用于滴定炭疽芽孢杆菌免疫抗原的琼脂扩散法及其在抗原生产研究中的应用。
J Gen Microbiol. 1957 Oct;17(2):505-16. doi: 10.1099/00221287-17-2-505.
10
Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity.体内培养的炭疽芽孢杆菌产生的聚谷氨酸;结构与侵袭素活性
Biochem J. 1956 Jul;63(3):437-42. doi: 10.1042/bj0630437.